Furthermore, the search for CK2 substrates in the CIGB-300 interactome revealed that the peptide is able to interact with substrates playing central roles in cancer cell physiology, such as protein DEK, G3BP1, HDAC2, DNA topoisomerase 1 and 2-alpha, and others with oncogenic potential. This evidence concerns the gene DEK and cancer.